CDKN2A and breast cancer: Furthermore, in breast cancer cell lines, loss of E-cadherin suppresses the activity of Ankyrin–NRAGE–p14ARF signaling to confer anoikis resistance (Kumar et al., 2011; Frisch et al., 2013).